NO DOCUMENTABLE ROLE FOR XANTHINE-OXIDASE IN THE PATHOGENESIS OF HEPATIC IN-VIVO ISCHAEMIA/REPERFUSION INJURY by G. CIGHETTI et al.
Pharmacological Research, Vol. 30, No. 3, 1994 243
NO DOCUMENTABLE ROLE FOR XANTHINE OXIDASE IN
THE PATHOGENESIS OF HEPATIC IN VIVO
ISCHAEMIA/REPERFUSION INJURY
GIULIANA CIGHETTI, SANDRA DEBIASI and RITA PARONII
Department of Medical Chemistry and Biochemistry, (Jniversity of Milan, and
lScientffic Instiîute San Raffaele, Milan,ltaly
Received in final form 2l May 1994
SUMMARY
An investigation was made into the possible involvemenî of the enzyme xanthine
oxidase (XO) (EC 1.1.3.22), both reversible (XOrev) and irreversible (XOirr), in
damage observed after short-term in vivo hepatic ischaemia/reperfusion (60 or
120 min I and 15 min R) in fasted rats with: (i) a physiological content of XO
(25Vo); and (ii) higher XO percentage (45Vo). In rhe larter rhe heparic XO
physiological percentage was increased by diethylmaleate treatment (300 mg kg-t)
that depleted the cytosolic glutathione (GSH) to l4%o of the controls. It was shown
that, in animals with physiological content of XO, 60 and 120 min of hepatic
ischaemia followed by l5 min reperfusion results in decreased GSH levels, and
significantly increased alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) serum levels, without any modification of either the
percentages of XO (XOirr and XOrev) or the hepatic thiobarbituric acid reactive
substances (TBARS). Sixty minutes of ischaemia/reperfusion in rats with the
higher XO level and lower hepatic GSH content led to further conversion of XDH
to Xorev, with no increase in Xoirr. In addition, the ALT and AST serum levels
in these animals rose to the same extent as in normal rats after 120 min ischaemia
and 15 min reperfusion, this extent being observed to be associated with a
moderate increase in thiobarbituric acid reactive substances (TBARS). However,
the administration of allopurinol, at a dose of 50 mg kg-t, which almost
completely inhibits Xo activity, did not lead to any decrease in liver damage or
TBARS. These findings exclude any role of Xo in liver damage in the short term
following ischaemia/reperfusion events, also when marked GSH depletion could
increase the enzymatic physiological XO level.
Ksv wonos: diethylmaleate, alanine and aspartate aminotransferase, thiobarbituric acid reactive
substances.
INTRODUCTION
Liver transplantation and surgery involving the liver is complicated by ischaemia.
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This has led to studies aimed at understanding the mechanism(s) of the structural
damage that occurs [7,2]. In fact, although some researchers have proposed the
involvement of oxygen free radicals [2-5], and the enzyme xanthine oxidase (XO)
which is a possible source of these radicals [5-10], the mechanism of ischaemic
tissue damage is still not fully understood. The involvement of XO was proposed
after the observation that during reoxygenation following ischaemia, high doses of
an XO inhibitor, allopurinol [11], limit cell damage 14,l2l. This hypothesis, on
which much research in this field is based, is founded on reports that the enzyme,
which in mammalian tissues exists predominantly as an NAD* reducing form
(xanthine dehydrogenase, XDH), can be converted into fwo oxygen radical-
producing forms (XO) by oxidation or by blocking the sulphydryl groups
(reversible XO, XOrev; reversed to XDH by dithiothreitol), or by limited
proteolysis (irreversible XO, XOirr) [3-16]. However, recent studies have
questioned this role of XO 111-191 and have proposed other sources for the toxic
oxygen products and liver damage 120-231. In fact, other studies have reported
that the XDH conversion to XOrev or XOirr proceeds slowly and begins only after
2 or 3h of hepatic ischaemia [7, 8, 10, l8], when the damage is already critical for
normal functional recovery |,231.
The aim of this study was to evidence or exclude the possible involvement of
XO in ischaemic liver damage in the period immediately following the onset of
reperfusion. Thus, hepatic ischaemia and ischaemia/reperfusion experiments were
performed on fasted normal rats and fasted rats with XO levels increased by the
chemical depletion of their endogenous cytosolic glutathione (GSH), this
depletion being obtained by i.p. administration of diethylmaleate (DEM)
according to a model we have already reported [24]. Thus it could be expected that
if XO is involved in hepatic ischaemia and reperfusion damage, such damage
should be increased in rats with the high XO percentages and, in theory, could be
prevented by inhibiting the XO activity. Furthermore, as it has been postulated
that XOrev precedes the formation of XOirr 18,251, the use of rats with increased
XOrev levels makes it possible to anticipate the XOirr formation during
ischaemia/reperfusion events.
Our results exclude any role of XO in ischaemic liver injury in a short period
immediately after the onset of reperfusion. In fact, neither the rats with a
physiological content of XOrev nor those with an increased XOrev content
showed any formation of XOirr during ischaemia/reperfusion, and the extent of
the damage observed was the same regardless of the XOrev or XOirr percentage
present. In addition, similar amounts of released hepatic enzymes and
thiobarbituric acid reactive substances (TBARS) were observed in all animals
subjected to ischaemia/reperfusion, and also in those pretreated with moderate
amounts of allopurinol which almost completely inhibits the total XO activity.
MATERIALS AND METHODS
Chemicqls
Xanthine, uric acid, NAD*, dithiothreitol (DTT), leupeptin and other chemicals
were purchased from Boehringer (Mannheim, F.R.G.); 2-thiobarbituric acid
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(TBA) was from Merck (Darmstadt, F.R.G.). Allopurinol (4-hydroxypyrazolo
13,4,-dl pyrimidine), purchased from Aldrich Chimica S.r.l. Milano, was
transformed into the sodium salt by treatment with a sodium hydroxide solution
and then lyophilized. All other chemicals were of analytical purity.
Animals and treatments
The studies on ischaemia/reperfusion were carried out on male Sprague-Dawley
rafs (200-250 g), eight rats in each group. All the animals were fasted overnight
for 15 h, subjected to ischaemia (I) or ischaemia/reperfusion (I/R) and then
decapitated between 8:00 and 9:00 hrs. The groups were:
(a) Normal controls: the rats were sham-operated, their vessels being manipulated
but not clamped. The animals were killed in accordance with the times of
those subjected to ischaemia.
(b) I and IIR in normal rats: ischaemia and ischaemia/reperfusion injuries were
induced as described below.
(c) IiR (120 minll1 min) in normal rats treated with allopurinol (50 mg kg-t, i.p.
18h and 60min before liver reperfusion): the sodium salt of allopurinol
corresponding to 200 mg allopurinol was dissolved in 5ml of 0.9Vo saline
solution; îhe i.p. administered volume was 0.25-0.3 ml.(d) GSH-depleted controls: the rats were sham-operated 10min after a single i.p.
injection of DEM (300 mg ke-t) 1241.(e) I and I/R in GSH-depleted rats: a single i.p. injection of DEM was made
10 min before ischaemia or ischaemia/reperfusion (explained below).(0 VR (60 min/15 min) in GSH-depleted rats pretreated with allopurinol
(50 mg kg-' i.p. 18 h and 60 min before liver reperfusion) and with DEM
(300 mg kg-t) 10 min before ischaemia/reperfusion.
The animals subjected to partial hepatic ischaemia were lightly anaesthetized
by diethyl ether. A midline incision was made in the abdomen and the hilar pedicle
of the left lateral and median lobes was clamped off with a microvessel clip [26].
The abdomen was closed with silk sutures and the rats allowed to awaken. After
60 or 120 min, the rats investigated for ischaemia were killed while those for
ischaemia/reperfusion were reoperated to remove the clamp and killed 15 min
after the restoration of the blood supply. The animals were killed by decapitation,
their blood collected and the serum separated from the clotted blood by
centrifugation at 3000 rpm for 10 min. For each rat the lateral and median lobes of
the liver were pooled and used to determine the GSH and oxidized glutathione
(GSSG) levels, and the TBARS and XO activity.
Preparation of enzyme frqction and evaluation of total (XDH+XO) and XO
activities
The liver lobes were removed quickly, washed and homogenized in 50 mv
phosphate buffer, pH 7.4, containing I mv EDTA (1:5, w/v); the conversion of
XDH to XO during handling was minimized by adding 10 mla 2-mercaptoethanol,
trypsin inhibitor (5 mg ml-l; type II-S from Sigma Chemical Co., Poole, U.K.)
[21] and leupeptin (0.5 mg l-t) to the buffer before use. Instead of DTT, 2-
mercaptoethanol was added to the buffer as a thiol group protector as it prevents
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XDH to XO transformation, without promoting the conversion of XO îo XDH
1271. The homogenate was centrifuged at 1500 g for 10 min and then at 105 000 g
for 60 min at 4'C. The supernatant was dialysed for at least 4 h against the same
homogenization buffer at 4"C [14]. Enzyme activity was measured by the method
reported by Cighetti et al. [28] with small modifications. For the evaluation of
total enzyme activity defined as XDH+XO, aliquots (0.2 ml) of dialyzed enzyme
fraction were preincubated for 30 min at 37"C in the presence of 10 mv DTT;
diluted aliquots (50 pg protein) were then incubated after the addition of 60,urra
xanthine and 0.67 mr'a NAD* for 10 min at 25'C (total volume 0.1 ml) l27l.DTT
preincubation was carried out to transform the XOrev into XDH. XOirr and total
XO (XOrev+XOirr) activities were determined in the absence of NAD*; for the
evaluation of total XO activity, DTT activation was avoided. Values of XOrev
activity were obtained by subtracting the XOirr value from that of total XO.
Incubation was stoppedby the addition of ethanol (1 ml), the samples ientrifuged
aî 1000 g for 5 min and the supernatants dried under nitrogen flow; the residues
were resuspended in 0. I mu NH4H2PO4, pH 7 (0.3 ml). Uric acid produced during
the reaction was measured by HPLC (Lichrosorb, RP-18 reverse phase column,
0.1 mv NH4H2PO4, pH 5.5, mobile phase, 1.5 ml min-r flow rate) [28], the peak
being detected at 292 nm. Total enzyme specific activity (XDH+XO) remained
unchanged in all tested groups (4+0.5 nmol uric acid per min per mg protein)
except for those treated with allopurinol. Each activity was expressed as a
percentage+se of total enzyme activity.
Protein concentralion
Protein concentration was determined according to Bradford [29] using bovine
serum albumin as a standard. The average protein content of the enzyme fraction
was 12 mg ml '.
Thiol determination
The total free (reduced and oxidized) and oxidized glutathione (GSSG) contents
were assayed enzymatically in liver lobes homogenized in 0.1 u phosphate buffer,
pH7.5, containing 5 mu EDTA [30]. In the evaluation of the GSSG level, l0mv
N-ethylmaleimide was added to the homogenizaiion buffer to avoid GSH auto-
oxidation.
ALT and AST serum level
The levels of serum alanine and aspartate aminotransferase (ALT and AST
respectively) were measured on a Hitachi l4l discrete automatic analyser (Hitachi
Ltd, Japan) with standard reagent supplied by Boehringer-Mannheim (Mannheim,
Germany). Values are given as units per litre of serum.
Assay of TBA reactive substances
This assay was carried out as an index of biomolecule oxidant damage. The
formation of thiobarbituric acid reactive substances (TBARS) was measured
colorimetrically using 1,1,3,3-tetraethoxypropane as the external standard
according to Ohkawa et al. t3 ll. Values are reported as nanomoles of
Pharmacological Research, Vol. 30, No. 3, 1994
Table I
Hepatic GSH and activity percentage of XO following in vivo rat liver
ischaemia and reperfusion
1Àa
Treatmenl A GSH Vo XO Total
(ltg 
^g-t protein) (XOrev+XOirr)
Vo XOirr Vo XOrev
Ischaemia
(min)
Reflow
(min)
Normal
0-
OU
60 15
120
120
120
GSH-depleted rats
0
6060 1560 15
15
15 +
+
12+1.0
8+1.1*
6+0.6*
7+0.5*
5+1.0*
4+1.0*
1.7+0.1*
1.6+0.3*
1 .2+0.1 *
1.0+0.2*
25t3
zSfz
26!2
25+l
25+2
<3t
À<+1*
70t3t
<3t
18+l 7!2
l8!2 6il
l8r1 '7!l
l8+1 5tl
18+l 6+1
<3+ <3t
23!0.5 22+l*
23!1.0 47!fi
24!0.3 48t21
<3+ <3+
Values of XO forms are expressed as percentage of total enzyme activily (XDH+XO)
which was 4+0.5 nmol uric acid per min per mg protein both in controls and GSH-depleted
rats submitted (or not) to ischaemia and reperfusion.
A: + rats (n=4) were treated with allopurinol (50 mg kg-') i.p. 18 h and t h before liver
reperfusion as reported in Materials and Methods; 
- 
rats untreated with allopurinol.
Each value is the mean*sE of triplicate determinations from eight rats.
*p<0.01 vs normal fasted control rats.
fp<0.01 vs GSH-depleted fasted control rats.
fAfter allopurinol treatment, total enzyme activity (XDH+XO) was reduced to 0.12+
0.05 nmol uric acid per min per mg protein; corresponding to 3Va of normal total activity.
malondialdehyde (MDA) per milligrams of protein and calculations were
performed using a linear regression program.
Statístics
Data are expressed as means+sE and the statistical significance was determined
using the Student's /-test.
RESULTS
Table I shows the hepatic levels of total free GSH (oxidized+reduced) and the
percentage of the different forms of XO determined in all experimental groups.
Normal fasted control rats showed GSH values in agreement with those previously
observed [24]. When normal rats were submitted to 60 and 120 min in vivo
ischaemia, the GSH levels reached, respectively, about 667o and 58Vo of that
observed in the fasted control animals, and fell to 50Vo and 41Vo when ischaemia
was followed by 15 min reperfusion.
The i.p. administration of DEM (300 mg kg-'), l0 min before inducing
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Table II
Evaluation of ALT and AST serum level and lipid peroxidation products
following in vivo rat liver ischaemia and reperfusion
Treatment A Serum (U l-') TBARS
(nmol MDA per mg
protein)Ishaemia(min)
Reflow
(min)
AST
;
l)
t)
;
l5
A: + rats (n=4) were treated with allopurinol (50 mg kg-t) i.p. 18 h and I h before liver
reperfusion as reported in Materials and Methods; 
- 
rats untreated with allopurinol.
Each value is the mean*sE of triplicate determination.
*p<0.01 vs normal fasted control rats.
tp<0.01 vs GSH-depleted fasted control rats.
ischaemia, depleted the GSH level to I4Va of that in the normal controls. This
depleted level was not significantly modified by the following reperfusion nor by
allopurinol treatment. No increase in the hepatic GSSG level (data noî shown) was
observed in any of the experimental groups (GSSG: 0.1-0.2 nmol per mg protein),
in agreement with the well documented relationship between intracellular GSSG
and its efflux into bile [21].
As far as XO is concerned, the normal fasted control rats showed percentages of
total XO (XOrev+XOirr; 25t3Ea) and XOirr (I8!lEa) in agreement with
previously reported values 18,24,271 (Table I). Furthermore, ín yivo ischaemia(60 or l20min) and ischaemia/reperfusion (60 or l20minll1 min) caused no
modification with respect to the controls. In accordance with previous results [24],
the GSH-depleted controls showed a two-fold increase in the percentage of total
XO (45+2Eo), and a three-fold increase in XOrev with respect to normal values. In
these animals ischaemia caused a significant (P<0.01) additional increase in total
XO (XOrev+XOirr) compared with their control animals, due exclusively to an
increase of XOrev. No additional increased in XOrev occurred during the
following reperfusion. Irreversible XO was not affected by either ischaemia or
reperfusion.
Allopurinol almost completely blocked the toral enzyme activity (XDH+XO) in
both normal and GSH-depleted rats subjected to ischaemia/reperfusion; in fact the
activity fell from 4+0.5 to 0.12+0.05 nmol per min per mg protein. Due to the low
fotal activity being equal to 3Vo of the normal value, the individual activity of the
different XO forms was not measured but is reported in Table I as <3Vo.
ALT
Normal
0
60
60
120
120
r20
GSH-depleted rats
0
60
60
60
73!2
80t3
500+30*
95t4
1000+25*
1010+20*
8515
1 5616*t
t225+50*I
1200+50*f
220+28
210+20
700+40*
220t20
I I 80+30*
l120+20*
2'10X23
490+42*I
1670+60*t
t 600+60*t
1.2+0.1
1.1!0.2
1.0r0.1
1.0t0.3
t.l+0.1
1.0+0.2
1.3!0.2
1.610.1
I 5+O 6*+
3.0+0.4*f
+
T
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After ischaemia and ischaemia/reperfusion, liver damage was monitored by
measuring serum ALT and AST levels while other damage attributable to
oxidation of biomolecules was assayed as TBARS (Table II). In normal rats none
of these parameters were affected after 60 and 120min ischaemia. However, the
ALT and AST serum values increased significantly after reperfusion with the
increased duration of ischaemia, despite the pretreatment with allopurinol.
After 60 min ischaemia, the GSH-depleted rats, with their high XOrev values,
showed a two-fold increase in serum ALT and AST values compared with normal
rats; reperfusion for 15 min increased these values even further and they reached
almost the same values as were observed in normal rats after 120 min ischaemia
followed by 15 min reperfusion (Table II). However, normal and GSH-depleted
rats pretreated with allopurinol and subjected to ischaemia/reperfusion showed no
modification in ALT and AST serum values with respect to those not treated.
TBARS variations were observed only in the liver of DEM treated (GSH-
depleted) animals after reperfusion, the levels appearing to be independent of any
allopurinol pretreatment of the animals.
DISCUSSION
In the present study the conversion of XDH into XO (XOrev and XOirr) was
studied after in vivo hepatic ischaemia and reperfusion in normal and GSH-
depleted rats. The latter showed an enhanced content of liver XOrev that could be
used to study the influence of the oxidized form of the XDH enzyme in liver
damage.
Liver damage and the conversion of XDH to XOrev and XOirr were assessed
after 60 and 120min of hepatic ischaemia as such times represent the critical
limits for normal functional recovery of ischaemic liver tl ,23l. The above
assessment was also made l5 min immediately after the onset of reperfusion to
avoid any modification of XO due to the pathophysiological process that occurs in
the late phases of reperfusion, and that could cause the conversion of XDH or
XOrev to XOirr by proteolysis.
The experiments carried out on normal rats showed the GSH content to be
depleted by up to 4l7o of the content in the controls during ischaemic episodes of
120min or less, even in the cases where 15 min reperfusion was carried out.
However, the XOrev and XOirr levels were unchanged, as was the total enzyme
activity (Table I). In all of the experiments no variation in TBARS was observed,
even in the presence of some hepatic eîzyme (ALT and AST) leakage that
occurred after 60 and l20min ischaemia/reperfusion (Table II). However, the
same release of hepatic enzymes was observed in rats pretreated with allopurinol
which almost completely blocks the total xanthine oxidase activity, thus the
leakage cannot be attributed to the presence of XO, but it could be from a different
source and is probably favoured by an enhanced vulnerability of the hepatocytes
due to GSH content depletion 132,331.
Ischaemia and ischaemia/reperfusion experiments performed on rats with
higher total XO levels than in normal rats led to the same conclusions. In fact,
60min of ischaemia caused an additional increase in total XO from 45 to 707o.
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This increase was due exclusively to Xorev since the Xoirr percentage was
unchanged (Table I). After restoration of the oxygen supply there was no further
or new conversion of XDH or XOrev to Xoirr, but there was a large release of
hepatic enzymes similar to that found for normal rats 120 min after
ischaemia/reperfusion. The only difference from normal rats was the increase in
TBARS, showing higher tissue vulnerability. Thus, since the high percentage of
XOrev was not followed by a comparable increase in the parameters that indicate
liver injury, our results lead us to suggest that the conversion of XDH to Xo
during ischaemia is only a secondary event. However since there is the possibility
that Xo is responsible for accelerating liver damage and increasing TBARS, we
performed ischaemia/reperfusion experiments on rats treaîed with both allopurinol
and DEM. However, even in these conditions, where Xo activity is almost
completely blocked, there was still liver damage.
In conclusion, we have set up a simple experimental model that allows us to
exclude any Xo role in the liver damage observed in short-term hepatic
ischaemia/reperfusion, also in rats with high Xo levels and greatly depleted in
GSH content.
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